Aspira Women's Health Reveals Private Placement Equity Financing Of $1.935M

The company announced it has entered into a securities purchase agreement dated June 30, 2024 with certain existing accredited shareholders and Company insiders to issue and sell an aggregate of 1.264 million shares of its common stock and warrants to purchase an equal number of shares of Common Stock at a combined offering price of $1.53 per share and warrant through a private placement financing.

The warrants will be exercisable for three years after date of issuance and have an exercise price of $2.25 per share.

Net proceeds from the Offering will support Aspira's ongoing commercial activities as well as general corporate purposes and working capital.